Edition:
United Kingdom

Konica Minolta Inc (4902.T)

4902.T on Tokyo Stock Exchange

994JPY
24 May 2019
Change (% chg)

¥-20 (-1.97%)
Prev Close
¥1,014
Open
¥1,008
Day's High
¥1,009
Day's Low
¥989
Volume
2,050,100
Avg. Vol
2,361,379
52-wk High
¥1,254
52-wk Low
¥934

Latest Key Developments (Source: Significant Developments)

R&I affirms Konica Minolta's rating at "A" and says stable outlook-R&I
Thursday, 13 Sep 2018 

Sept 13 (Reuters) - Konica Minolta Inc <4902.T>:Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A"-R&I.Rating outlook stable-R&I .  Full Article

Mobotix: Konica Minolta Invests EUR 1.5 Mln In Technology Development Of Mobotix
Monday, 26 Mar 2018 

March 26 (Reuters) - MOBOTIX AG ::KONICA MINOLTA IS INITIALLY INVESTING 1.5 MILLION EUROS IN THE TECHNOLOGY DEVELOPMENT OF MOBOTIX.  Full Article

Konica Minolta unit and INCJ buy Ambry Genetics
Thursday, 19 Oct 2017 

Oct 19(Reuters) - Konica Minolta Inc <4902.T>:Says its U.S.-based unit Konica Minolta Healthcare Americas, Inc. and Innovation Network Corporation of Japan (INCJ)jointly bought U.S.-based company Ambry Genetics Corporation.Purchase plan was announced on July 6.  Full Article

R&I affirms Konica Minolta's rating at "A" and says stable outlook-R&I
Thursday, 27 Jul 2017 

July 27 (Reuters) - Konica Minolta Inc <4902.T>:Says Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A" -R&I.Says rating outlook stable -R&I.  Full Article

Konica Minolta to buy Ambry Genetics for $1 bln
Thursday, 6 Jul 2017 

July 6 (Reuters) - Konica Minolta Inc <4902.T>::Konica Minolta to acquire U.S.-based Ambry Genetics in a deal valued at US$1 billion.Transaction is partially funded by Innovation Network Corporation of Japan.$800 million to be paid upon closure, there will be additional payment of up to $200 million based on certain financial metrics over next 2 years.Ambry would become consolidated unit of Konica Minolta, continuing to operate under Ambry name, headquartered in Aliso Viejo, California.  Full Article